Cargando…
Revisiting entinostat as an immune-potentiating adjuvant
Autores principales: | McCaw, Tyler R., Randall, Troy D., Arend, Rebecca C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324670/ https://www.ncbi.nlm.nih.gov/pubmed/30647864 http://dx.doi.org/10.18632/oncotarget.26453 |
Ejemplares similares
-
Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer
por: McCaw, Tyler R., et al.
Publicado: (2020) -
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2019) -
Targeting SALL4 by entinostat in lung cancer
por: Yong, Kol Jia, et al.
Publicado: (2016) -
Entinostat-Bortezomib Hybrids against Multiple Myeloma
por: Ferro, Angelica, et al.
Publicado: (2023) -
A Biological Model for Influenza Transmission: Pandemic Planning Implications of Asymptomatic Infection and Immunity
por: Mathews, John D., et al.
Publicado: (2007)